Overview

Effect of Methylnaltrexone (Relistor) on Digestion and Tolerance to Tube Feeding in Patients Treated With Opiates

Status:
Withdrawn
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
It is hypothesized that using methylnaltrexone in addition to pain killer narcotics (opiates) in patients will result in increased tube feeding rates with more frequent nutrition at goal calorie rate.
Phase:
Phase 3
Details
Lead Sponsor:
Drexel University
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Methylnaltrexone
Naltrexone